Chartwell Investment Partners, LLC Abb Vie Inc. Transaction History

Chartwell Investment Partners, LLC

$2.91 Billion
Q3 2024

A detailed history of Chartwell Investment Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 116,490 shares of ABBV stock, worth $19.9 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

116,490

Previous 125,728 7.35%

Holding current value

$19.9 Million

Previous $21.6 Million 6.67%

% of portfolio

0.79%

Previous 0.76%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$163.84 - $199.33 $1.51 Million - $1.84 Million	-9,238 Reduced 7.35%	116,490 $23 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $2.53 Million - $2.95 Million	16,340 Added 14.94%	125,728 $21.6 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $2.35 Million - $2.68 Million	-14,704 Reduced 11.85%	109,388 $19.9 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $351,705 - $396,103	-2,556 Reduced 2.02%	124,092 $19.2 Million
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $375,922 - $435,185	-2,814 Reduced 2.17%	126,648 $18.9 Million
Q2 2023 Jul 25, 2023	SELL	$132.51 - $164.9 $313,386 - $389,988	-2,365 Reduced 1.79%	129,462 $17.4 Million
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $777,423 - $895,319	5,376 Added 4.25%	131,827 $21 Million
Q4 2022 Feb 15, 2023	BUY	$138.31 - $165.87 $2.07 Million - $2.48 Million	14,949 Added 13.41%	126,451 $20.4 Million
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $1.71 Million - $1.96 Million	12,731 Added 12.89%	111,502 $15 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $1.79 Million - $2.27 Million	13,002 Added 15.16%	98,771 $15.1 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $1.82 Million - $2.26 Million	-13,801 Reduced 13.86%	85,769 $13.9 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $4.62 Million - $5.84 Million	42,985 Added 75.97%	99,570 $13.5 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $5,532 - $6,280	-52 Reduced 0.09%	56,585 $6.1 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $5.96 Million - $6.64 Million	56,637 New	56,637 $6.38 Million
Q2 2019 Aug 19, 2019	SELL	$65.7 - $83.98 $3.03 Million - $3.88 Million	-46,189 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$77.14 - $90.79 $156,208 - $183,849	2,025 Added 4.59%	46,189 $3.72 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $1.96 Million - $2.42 Million	-25,214 Reduced 36.34%	44,164 $4.07 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $195,157 - $216,953	-2,195 Reduced 3.07%	69,378 $6.56 Million
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $3.35 Million - $3.96 Million	37,308 Added 108.88%	71,573 $6.63 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $2.39 Million - $3.06 Million	34,265	34,265 $3.04 Million

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Account

Chartwell Investment Partners, LLC Abb Vie Inc. Transaction History